-
Study aim
-
To investigate the healing status, reduction of wound surface, wound infection, reduction of pain, rate of healing, and length of hospital stay of patients using new dressings compared to silver sulfadiazine ointment in patients with 2nd and 3rd degree burns.
-
Design
-
A randomized, open-label, parallel-group, controlled clinical trial, phase 3, on 74 patients
-
Settings and conduct
-
Patients with 2nd and 3rd degree burns admitted to Taleghani Hospital in Ahvaz, after excision of the wounds in the operating room, are divided into two groups: a new aluminum-based dressing and the other group is given SSD ointment, and the wound condition is re-evaluated 5 days later.
-
Participants/Inclusion and exclusion criteria
-
Patients with 2nd and 3rd degree burns, failure to use medications effective in wound healing, and wounds without trauma or infection are inclusion criteria. Patients with wounds containing necrotic and infected tissue, and patients with trauma and first degree burns are excluded
-
Intervention groups
-
Patients with 2nd and 3rd degree burns hospitalized under a new aluminum-based dressing compared to a dressing with silver sulfadiazine ointment
-
Main outcome variables
-
The results of this study will greatly assist us in selecting the type of dressing to accelerate the healing process, reduce the risk of infection, reduce the surface area and the number of cases requiring dressings in second- and third-degree burn wounds, as well as reduce the use of antibiotics and prevent the development of drug resistance